证券代码：600299 证券简称：安迪苏 公告编号：2024-031 蓝星安迪苏股份有限公司 第八届董事会第十九次会议 决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 蓝星安迪苏股份有限公司（以下简称"安迪苏"或"公司"）第八届董事会 第十九次会议于 2024 年 8 月 29 日以通讯表决的方式召开。董事会会议通知和材 料于 2024 年 8 月 19 日以电子邮件方式发出。会议应参加表决董事 9 人，实际参 加表决董事 9 人。本次会议符合《中华人民共和国公司法》和《蓝星安迪苏股份 有限公司章程》的有关规定。本次会议由董事长郝志刚先生召集和主持。 参加会议的董事表决通过以下议案： 1. 审议通过关于《2024 年半年度报告及其摘要》的议案 薪酬与考核委员会基于公司国际化的经营情况，对比全球同行业水平，审议 通过了关于第九届董事会独立董事津贴，认为其结合了公司实际经营情况， 不存在损害公司或中小股东利益的情形，同意提请董事会审议。 关联董事臧恒昌回避表决。 审计、风险及合规委员会审议同意上述议案。 《 2024 年 ...

Financial Performance - The company's revenue for the first half of 2024 reached CNY 7,260,948,548, representing a 14.74% increase compared to CNY 6,328,375,755 in the same period last year[21]. - Net profit attributable to shareholders was CNY 607,599,304, a significant increase of 1,719.14% from CNY 33,400,286 in the previous year[21]. - The net profit after deducting non-recurring gains and losses was CNY 704,686,306, up 6,522.57% from CNY 10,640,672 year-on-year[21]. - Basic earnings per share increased to CNY 0.23, a rise of 2,200.00% compared to CNY 0.01 in the same period last year[22]. - The weighted average return on net assets rose to 4.00%, an increase of 3.78 percentage points from 0.22% in the previous year[22]. - The gross profit for the first half of 2024 was RMB 2.28 billion, representing a 71% increase from RMB 1.33 billion in the previous year, with a gross margin of 31%, up 10 percentage points[47]. - The net profit attributable to shareholders surged to RMB 610 million, a staggering increase of 1719% from RMB 30 million in the first half of 2023[47]. - Functional products generated RMB 5.39 billion in revenue, a 20% increase year-over-year, while specialty products saw a slight increase to RMB 1.87 billion, up 1%[47]. Risk Management - There are no significant risks that materially affect the company's production and operations during the reporting period[7]. - The company emphasizes the importance of risk management and has outlined various risks and countermeasures in the report[7]. - The company has identified seven categories of risks, including political, economic, and environmental risks, which could impact its global operations[62]. - The company faces risks related to compliance, including potential legal and reputational risks from violations of anti-corruption and competition laws[63]. - The company is exposed to significant risks from raw material and energy supply fluctuations, with key materials including propylene, sulfur, methanol, ammonia, and natural gas[68]. - The company faces foreign exchange risks due to its operations primarily in currencies like the Euro and USD, impacting its financial performance[71]. - The company is subject to industrial risks that could lead to civil, criminal, or environmental liabilities, particularly in relation to hazardous chemicals[74]. Environmental Responsibility - The company has a commitment to environmental and social responsibility, as detailed in the report[9]. - The company aims to reduce greenhouse gas emissions by 21% and energy consumption by 13% by 2025 compared to 2020 levels, with energy consumption intensity reduced by 20% from 2015 levels[28]. - The company has implemented a comprehensive environmental management system in line with the FORUS framework to enhance its environmental performance[95]. - The company has successfully completed the construction of wastewater treatment and reclaimed water reuse projects, with civil works currently underway[101]. - The company reported that emissions of sulfur dioxide (SO2) were 3.24 tons, nitrogen oxides (NOx) were 66.65 tons, and particulate matter (Dust) were 2.12 tons, all within the permissible limits[97]. - The company has maintained compliance with environmental laws and regulations, with no environmental pollution incidents reported during the reporting period[106]. Product Development and Innovation - The company has a focus on developing new products and technologies, particularly in the field of animal nutrition additives[13]. - The company has launched new products such as RumenSmart® and Smartamine®ML to enhance its ruminant product line, focusing on improving milk quality and cow health[32]. - The company is actively developing new products and solutions to reduce antibiotic use and improve animal health, particularly in challenging growth environments[34]. - The company has established a global R&D center with approximately 300 employees dedicated to research and innovation, supporting its dual pillar strategy[28]. - The company has invested in research and development to innovate and improve production processes, with risks of project termination due to market or regulatory changes[69]. Market Expansion and Acquisitions - The company is actively pursuing market expansion and acquisitions, including the acquisition of FRAmelco Group in December 2020[13]. - The acquisition of FRAmelco has strengthened the company's leadership in the rapidly growing "nutrition promoting health" market[28]. - The company serves over 4,200 customers across more than 110 countries, focusing on improving production efficiency and animal health while minimizing environmental impact[27]. - The company is enhancing its global methionine and specialty products layout to meet customer demands amid increasing geopolitical risks[28]. Financial Management - The company reported a decrease in operating costs to RMB 4.98 billion, down 0.29% from RMB 4.99 billion in the previous year[50]. - The company is implementing a cost reduction plan expected to yield benefits of RMB 156 million for the full year[48]. - The company has maintained its industry-leading position in research and innovation since launching solid methionine in 1945, being the first to synthesize methionine and develop innovative products for ruminants[43]. - The company has integrated the product portfolios of Neovia, FRAmelco, and Nor-Feed to provide comprehensive solutions addressing various challenges faced by farmers and feed producers[37]. Corporate Governance - The company reported no profit distribution plan or capital reserve transfer plan during the reporting period[6]. - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties[6]. - The company has not violated decision-making procedures for providing guarantees[6]. - The company held its annual general meeting on June 26, 2024, where all proposed resolutions were approved, including the profit distribution plan and the adjustment of the long-term dividend policy[90]. - There was a change in senior management, with Gu Dengjie resigning as Deputy General Manager effective July 5, 2024, due to retirement[92].

证券代码：600299 证券简称：安迪苏 公告编号：2024-034 蓝星安迪苏股份有限公司 关于召开 2024 年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东大会类型和届次 2024 年第一次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2024 年 9 月 19 日 14 点 00 分 召开地点：北京市朝阳区北土城西路 9 号蓝星大厦会议室 (五)网络投票的系统、起止日期和投票时间。 股东大会召开日期：2024年9月19日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2024 年 9 月 19 日 至 2024 年 9 月 19 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的 ...

证券代码：600299 证券简称：安迪苏 公告编号：2024-032 蓝星安迪苏股份有限公司 第八届监事会第十三次会议 决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 1 摘要》编制和审议的人员有违反保密规定的行为。 因此，公司监事会保证公司公告的《2024 年半年度报告及其摘要》内容真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 蓝星安迪苏股份有限公司（以下简称"公司"）第八届监事会第十三次会议 于 2024 年 8 月 29 日以通讯表决的方式召开。监事会会议通知和材料于 2024 年 8 月 19 日以电子邮件方式发出。会议应参加表决监事 3 人，实际参加表决监事 3 人。 本次会议符合《中华人民共和国公司法》和《蓝星安迪苏股份有限公司章程》(以 下简称"《公司章程》")的有关规定。本次会议由王岩先生召集。 参加会议的监事表决通过以下议案： 1. 审议通过关于《2024 年半年度报告及其摘要》的议案 《 2024 年 半 年 度 报 告 及 其 摘 要 》 内 容 详 见 上 海 证 券 交 易 所 ...

证券代码：600299 证券简称：安迪苏 公告编号：2024-030 蓝星安迪苏股份有限公司 关于召开 2024 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 蓝星安迪苏股份有限公司（以下简称"公司"）将于 2024 年 8 月 30 日披露公 司 2024 年半年度报告，为便于广大投资者更全面深入地了解公司 2024 年半年度 业绩经营成果、财务状况，公司计划于 2024 年 9 月 4 日下午 15:00-16:30 举行 2024 年半年度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以视频直播和网络互动形式召开，公司将针对 2024 年半 年度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披 露允许的范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 三、 参加人员 董事长兼总经理（CEO）：郝志刚先生 独立董事：臧恒昌先生 副总经理兼首席运营官：Frederic Jacquin 先生 （一）会议召开时间：20 ...

证券代码：600299 证券简称：安迪苏 公告编号：2024-029 蓝星安迪苏股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利 0.06 元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2024/8/12 | － | 2024/8/13 | 2024/8/13 | 差异化分红送转： 否 本次利润分配方案经公司 2024 年 6 月 26 日的 2023 年年度股东大会审议通过。 一、 通过分配方案的股东大会届次和日期 二、 分配方案 1. 发放年度：2023 年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本 2,681,901, ...

2024 年 7 月 12 日 公司研究 蛋氨酸业务增长强劲,Q2 业绩大幅增长 ——安迪苏(600299.SH)2024 年半年度业绩预增公告点评 买入(维持) 当前价:10.15 元 作者 分析师:赵乃迪 执业证书编号:S0930517050005 010-57378026 zhaond@ebscn.com 分析师:蔡嘉豪 | | | |---------------------|----------------| | 执业证书编号: | S0930523070003 | | 021-52523800 | | | caijiahao@ebscn.com | | | 市场数据 | | | 总股本(亿股) | 26.82 | | 总市值(亿元): | 272.21 | | 一年最低/最高(元): | 6.45/10.44 | | 近 3 月换手率: | 20.86% | 股价相对走势 -18% -6% 5% 17% 28% 07/23 10/23 01/24 04/24 安迪苏 沪深300 收益表现 | | | | | |------|------|-------|-------| | % | 1M | 3M ...

Financial Performance - The company expects a net profit attributable to shareholders for the first half of 2024 to be between 550 million and 650 million yuan, an increase of 516.6 million to 616.6 million yuan compared to the same period last year, representing a year-on-year increase of 1546.71% to 1846.11%[1] - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between 650 million and 750 million yuan, an increase of 639.36 million to 739.36 million yuan compared to the same period last year, representing a year-on-year increase of 6009.02% to 6948.87%[1] - The previous year's net profit attributable to shareholders was 33.4 million yuan, with a net profit after deducting non-recurring gains and losses of 10.64 million yuan[2] Business Performance - The strong growth in the company's methionine business is attributed to the continued penetration of liquid methionine and stable sales prices[3] - The specialty products business remains vibrant, particularly with rapid growth in monogastric animal products and aquatic products, despite a slight downturn in ruminant business due to low milk prices in the U.S.[3] - Decreased raw material and energy costs, along with effective management of global supply chains, distribution channels, and tariffs, contributed to the performance[3] - Strict cash and working capital management, along with ongoing cost control and competitiveness enhancement plans, supported the significant profit increase[3] - The company has maintained a strong operational momentum in Q2 2024, continuing the positive trend from Q1[3] Forecast and Risks - The performance forecast is based on preliminary estimates and has not been audited by an accounting firm[4] - Investors are advised to pay attention to investment risks as the specific financial data will be confirmed in the company's 2024 semi-annual report[4]

证券代码：600299 证券简称：安迪苏 编号：2024-027 蓝星安迪苏股份有限公司 关于公司副总经理辞职的公告 公司副总经理顾登杰先生因退休安排，申请自 2024 年 7 月 5 日起辞去公司 副总经理职务。辞职后，顾登杰先生将不在公司担任任何职务。 顾登杰先生在任职期间恪尽职守、勤勉尽责，公司及董事会对其在担任公 司副总经理期间为公司发展及规范运作方面做出的贡献表示衷心的感谢。 特此公告。 蓝星安迪苏股份有限公司董事会 2024 年 7 月 5 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 蓝星安迪苏股份有限公司（以下简称"公司"）董事会于近日收到公司副总 经理顾登杰先生的书面辞职报告。具体情况如下： ...

北京市金杜律师事务所上海分所 为出具本法律意见书，金杜律师审查了安迪苏提供的以下文件，包括但不限于： 1. 经蓝星安迪苏股份有限公司 2021 年第一次临时股东大会审议通过的《蓝星安 迪苏股份有限公司章程》（以下简称《公司章程》）； 2. 安迪苏 2024 年 3 月 29 日刊登于巨潮资讯网及上海证券交易所网站的《蓝星安 迪苏股份有限公司第八届董事会第十七次会议决议公告》《蓝星安迪苏股份 有限公司第八届监事会第十一次会议决议公告》，2024 年 4 月 26 日刊登于巨 潮资讯网及上海证券交易所网站的《蓝星安迪苏股份有限公司第八届董事会 第十八次会议决议公告》《蓝星安迪苏股份有限公司第八届监事会第十二次 会议决议公告》《蓝星安迪苏股份有限公司第八届董事会独立董事专门会议 第二次会议决议公告》； 安迪苏已向金杜保证，安迪苏已向金杜披露一切足以影响本法律意见书出具的事 实并提供了金杜为出具本法律意见书所要求安迪苏提供的原始书面材料、副本材料、 复印材料、承诺函或证明，并无隐瞒记载、虚假陈述和重大遗漏之处；安迪苏提供给 金杜的文件和材料是真实、准确、完整和有效的，且文件材料为副本或复印件的，其 与原件一致和相符。 ...